atorvastatin has been researched along with Hematuria in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, AR; Dunning, SC; Fine, DM; Grams, ME; Inker, LA; Nolin, TD; Sang, Y; Shin, JI; Surapaneni, A | 1 |
| Bruggisser, M; Haschke, M; Rätz Bravo, A; Terraciano, L | 1 |
| Gibson, E; Luo, D; Newman, C; Szarek, M; Tsai, J | 1 |
| Cairns, T; Cook, HT; Elliot, V | 1 |
1 review(s) available for atorvastatin and Hematuria
| Article | Year |
|---|---|
Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Albuminuria; Aspartate Aminotransferases; Atorvastatin; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Utilization; Female; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pain; Pyrroles; Retrospective Studies | 2006 |
3 other study(ies) available for atorvastatin and Hematuria
| Article | Year |
|---|---|
Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria.
Topics: Atorvastatin; Hematuria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Proteinuria; Renal Insufficiency, Chronic; Rosuvastatin Calcium | 2022 |
[Liver damage in a patient treated with a vitamin K antagonist, a statin and an ACE inhibitor].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Atorvastatin; Biopsy; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Therapy, Combination; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Function Tests; Male; Perindopril; Phenprocoumon; Pyrroles; Vitamin K | 2010 |
Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Biopsy, Needle; Disease Progression; Follow-Up Studies; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Organelles; Plasma Exchange; Pyrroles; Sclerosis; Severity of Illness Index; Software Design | 2006 |